2020
DOI: 10.32771/inajog.v8i4.1342
|View full text |Cite
|
Sign up to set email alerts
|

Risk of Malignancy Index 4 (RMI4) and Risk of Malignancy Index 3 (RMI3) as Diagnostic Tests for Adnexal Tumor

Abstract: Objective: Comparing scoring with RMI3 and RMI4 in establishing the diagnosis of adnexal tumour in RSUD Dr. Saiful Anwar Malang.Methods: Prospective cohort study with samples of all patients suspected of having an adnexal tumour diagnosed in gynecology policlinic using gynecological oncology policlinic medical records at RSUD Dr. Saiful Anwar in the form of age, demographics, menopause status, Ca125, ultrasound results.Results: Between the RMI3 results and the results of histopathology, a contingency coeffi ci… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
1
0
0
Order By: Relevance
“…Meanwhile, based on the Holland-Frei Cancer Medicine 6th edition, the mean age of patients diagnosed with ovarian epithelial carcinoma is between the ages of 60 and 65 years (Berek and Bast Jr 2003). The mean age of women with ovarian epithelial carcinoma in this study is also in line with research conducted at the RSSA gynecology poly oncology in 2019, 54.2 ± 10.3 (Nurseta et al 2020).…”
Section: Rmi 4 Accuracy Level As a Predictor Of Advanced Epithelial Ovarian Carcinomasupporting
confidence: 88%
“…Meanwhile, based on the Holland-Frei Cancer Medicine 6th edition, the mean age of patients diagnosed with ovarian epithelial carcinoma is between the ages of 60 and 65 years (Berek and Bast Jr 2003). The mean age of women with ovarian epithelial carcinoma in this study is also in line with research conducted at the RSSA gynecology poly oncology in 2019, 54.2 ± 10.3 (Nurseta et al 2020).…”
Section: Rmi 4 Accuracy Level As a Predictor Of Advanced Epithelial Ovarian Carcinomasupporting
confidence: 88%